Dragon Pharma, Europe
Testabol 400
Injection · 400 mg/ml · 10 ml
Compound ID
Testosterone Acetate / Testosterone Enanthate / Testosterone Decanoate
Dosage
400 mg/week
Concentration
400 mg/mL
Form
10 mL Multi-Dose Vial
Half-life
10–14 days
Properties
Product overview
Dragon Pharma Testabol 400mg/mL — Triple-Ester Testosterone Matrix for Sustained Anabolic Drive, Peak Mass Accretion & Streamlined Injection Protocols
Dragon Pharma Testabol 400mg/mL represents a masterfully engineered multi-ester testosterone platform designed for the experienced athlete who demands both immediate hormonal elevation and extended anabolic stability within a single, high-concentration injection. By strategically combining Testosterone Acetate, Testosterone Enanthate, and Testosterone Decanoate in a precisely calibrated 400mg per milliliter formulation, this blend delivers a pharmacokinetic profile that bridges rapid onset, sustained peak activity, and prolonged clearance—eliminating the need for multiple separate vials and injection schedules.
The acetate fraction ignites anabolic signaling within days, the enanthate backbone maintains robust testosterone levels through the mid-cycle phase, and the decanoate component ensures hormonal continuity into the final weeks. For advanced bodybuilders pursuing aggressive bulking cycles, strength-focused protocols, or long-term mass-building regimens, Dragon Pharma's sterile, pharmaceutical-grade Testabol 400 offers a verified, high-potency solution that simplifies logistics while maximizing physiological output.
What is Dragon Pharma Testabol 400?
Testabol 400 is a sterile oil-based injectable solution containing three distinct testosterone esters in a single, high-concentration blend. Each milliliter delivers 60mg of Testosterone Acetate, 142mg of Testosterone Enanthate, and 198mg of Testosterone Decanoate, totaling 400mg of testosterone hormone per milliliter.
This triphasic ester architecture creates a composite release curve: the short-acting acetate ester (approximately 48–72 hour half-life) provides rapid elevation of serum testosterone within 24–48 hours of administration; the intermediate enanthate ester (approximately 5–7 day half-life) sustains peak anabolic concentrations through the central weeks of the cycle; and the long-acting decanoate ester (approximately 10–14 day half-life) extends hormonal stability and reduces the frequency of late-cycle injections.
Unlike single-ester testosterone preparations that produce pronounced peak-trough fluctuations, this blend smooths plasma concentration curves, supporting more consistent nitrogen retention, protein synthesis, and mood stability. Dragon Pharma's pharmaceutical manufacturing ensures sterility, precise ester ratio maintenance, and batch-to-batch potency consistency.
Key Benefits / Effects
- Triphasic Hormonal Kinetics: The strategic combination of short, intermediate, and long esters produces immediate anabolic activation, sustained mid-cycle peak levels, and extended late-cycle stability without the hormonal rollercoaster of single-ester protocols.
- Reduced Injection Frequency: The decanoate component's prolonged half-life allows for twice-weekly administration while maintaining stable serum testosterone, reducing injection site trauma and logistical complexity compared to daily or EOD short-ester protocols.
- Accelerated Lean Hypertrophy: The combined 400mg per milliliter concentration delivers robust anabolic signaling that supports significant muscle protein synthesis, nitrogen supercompensation, and myofibrillar expansion when paired with high-protein nutrition and progressive resistance training.
- Explosive Strength Escalation: Rapid elevation of free testosterone enhances neuromuscular transmission efficiency, enabling heavier compound lifts, greater training volume, and consistent progressive overload capacity throughout the cycle.
- Enhanced Recovery & Tissue Repair: Elevated testosterone levels accelerate satellite cell recruitment, collagen synthesis, and glycogen replenishment, shortening inter-session recovery intervals and reducing delayed-onset muscle soreness.
- Optimized Libido & Psychological Drive: The androgenic signaling from all three esters supports sexual function, mood stability, training aggression, and overall sense of vitality—factors frequently compromised during intensive training blocks or hypocaloric phases.
How Dragon Pharma Testabol 400 Works
The blend operates through three convergent pharmacokinetic pathways that collectively maintain elevated serum testosterone across extended timeframes. Upon intramuscular injection, the acetate ester undergoes rapid enzymatic hydrolysis, releasing free testosterone into circulation within 24–48 hours and producing an immediate anabolic and androgenic signal. Simultaneously, the enanthate ester enters a slower cleavage phase, building toward peak plasma concentrations over 3–5 days and sustaining robust testosterone levels through the intermediate cycle period.
The decanoate ester, with its extended fatty acid chain, undergoes gradual hydrolysis over 10–14 days, creating a hormonal reservoir that prevents the sharp decline characteristic of shorter esters as the cycle progresses. Once liberated, free testosterone binds to androgen receptors in skeletal myocytes, activating genomic pathways that upregulate muscle-specific protein synthesis, enhance nitrogen retention, and stimulate erythropoietin release.
The aromatization of a portion of this testosterone to estradiol supports joint lubrication, mood regulation, and HDL cholesterol maintenance, while the 5-alpha-reduced fraction converts to dihydrotestosterone, amplifying androgenic effects in skin, scalp, and prostate tissues. The net result is a sustained, multi-phase anabolic environment optimized for long-term mass and strength development.
Usage Information
Dragon Pharma Testabol 400 is supplied as a 400mg per milliliter oil-based injectable solution in 10mL multi-dose vials, designed exclusively for intramuscular administration by experienced male athletes. Due to the presence of both short and long esters, a twice-weekly injection schedule—typically Monday and Thursday or Tuesday and Friday—maintains stable plasma concentrations while accommodating the decanoate component's extended release.
Standard weekly dosages range from 400mg to 800mg, translating to 1.0–2.0mL total volume split evenly between two injections. Beginner users of high-concentration blends should initiate at 400–500mg weekly to assess individual tolerance, injection site comfort, and estrogenic response. Intermediate practitioners typically employ 600mg weekly, while advanced users may explore 800mg weekly under comprehensive health monitoring.
Cycle duration generally spans 12–16 weeks, with the blend serving as the foundational anabolic driver around which oral kickstarters and secondary injectables are stacked. The high concentration (400mg/mL) means that injection volumes are moderate even at elevated weekly totals—1.5mL split into two 0.75mL injections delivers 600mg weekly. Intramuscular sites should rotate among gluteal, deltoid, and vastus lateralis muscles to prevent localized tissue irritation. Aromatase inhibitor management is mandatory, and Post-Cycle Therapy must account for the decanoate ester's extended clearance window.
Quality & Manufacturing
Dragon Pharma enforces uncompromising pharmaceutical manufacturing standards across all injectable production lines, with each Testabol 400 batch subjected to independent third-party laboratory analysis to verify sterility, active ingredient concentration, endotoxin levels, and heavy metal absence. The compounding of three distinct testosterone esters at a high 400mg per milliliter concentration presents significant manufacturing challenges, requiring sophisticated solubilization technology to prevent crystallization, maintain uniform distribution, and ensure smooth injection viscosity. Dragon Pharma's analytical verification confirms that each vial delivers exactly the stated 400mg per milliliter total concentration, with individual ester ratios maintained within tight pharmaceutical tolerances. In the high-concentration testosterone marketplace, where crystallized products, inconsistent ester ratios, and bacterial contamination are genuine risks, this commitment to manufacturing precision and batch transparency provides advanced users with the confidence to program extended bulking cycles without the uncertainty of variable potency or compromised sterility.
Possible Side Effects / Safety Information
- Estrogenic Complications: Testosterone aromatizes readily to estradiol via the aromatase enzyme, creating risk of gynecomastia, subcutaneous water retention, elevated blood pressure, and fat deposition. Proactive aromatase inhibitor management is essential.
- Androgenic Manifestations: Users may experience increased sebaceous activity causing acne and oily skin, accelerated male pattern baldness in genetically predisposed individuals, and increased terminal hair growth due to DHT conversion.
- Cardiovascular Dyslipidemia: Exogenous testosterone can depress HDL cholesterol while elevating LDL cholesterol and triglycerides, particularly at higher doses and extended durations. Dietary omega-3s and cardiovascular exercise are recommended.
- Profound HPTA Suppression: All three esters suppress endogenous testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis. Comprehensive Post-Cycle Therapy is mandatory following cycle cessation.
- Hematocrit Elevation: Stimulated erythropoiesis increases red blood cell mass and blood viscosity, potentially elevating blood pressure and thrombotic risk. Monitoring and therapeutic phlebotomy may be necessary.
- Injection Site Reactions: The high 400mg/mL concentration may produce post-injection pain, localized swelling, or warmth in sensitive individuals; proper technique, site rotation, and moderate injection volumes mitigate these effects.
- Psychological Androgenicity: Some users report increased irritability, aggression, or mood fluctuations consistent with elevated androgen levels.
- Prostate Considerations: DHT conversion may stimulate prostate tissue; older users or those with family history should monitor urinary symptoms.
Why Choose Dragon Pharma Testabol 400?
Managing a multi-ester testosterone protocol using separate vials introduces significant logistical complexity, dosing calculation errors, and inconsistent carrier oil volumes that can compromise both results and user experience. Dragon Pharma's pre-formulated Testabol 400 eliminates these variables by integrating three strategically selected esters into a single, verified, sterile solution.
This integration ensures pharmacokinetic harmony—the acetate fraction ignites immediate progress while the enanthate and decanoate components sustain and extend the anabolic window. The high 400mg per milliliter concentration reduces total injection volume, making even advanced weekly dosages manageable with modest 1.0–1.5mL split injections.
For the experienced athlete who understands that successful bulking requires not just raw hormone quantity but sustained, stable plasma levels that maximize nitrogen retention and minimize side-effect volatility, this blend offers a streamlined, pharmaceutical-grade platform. Dragon Pharma's batch testing and sterility assurance transform complex multi-ester protocols into an efficient, predictable pathway to substantial mass and strength accretion.
Lab Report
Lab Report: 399 mg/ml
25 Mar 2026
400 mg/ml of label claim
| Analysis Date | 2026-03-25 |
| Lot / Batch ID | #TESTBMT6 |
| Measured Potency | 399 mg/ml |
| Quality Assessment | Potency verified, purity passed, heavy metals passed. |
| Current Production Batch | Latest Batch |
Verify this result with your scratch-off code at the DPStore register.
Product FAQ
Questions, answered
Single-ester preparations produce a single pharmacokinetic curve with pronounced peak-trough fluctuations, often requiring more frequent injections to maintain stability. Testabol 400's tri-ester architecture creates a composite release profile: the acetate component provides immediate activity, the enanthate sustains mid-cycle peaks, and the decanoate extends the anabolic window into late-cycle weeks. This results in smoother serum testosterone levels, more consistent mood and libido, reduced injection frequency compared to pure short esters, and a more seamless transition into Post-Cycle Therapy.
The decanoate ester serves a critical strategic function in extended 12–16 week cycles. While enanthate peaks and begins declining by week 6–8, decanoate's 10–14 day half-life creates a hormonal reservoir that prevents the sharp late-cycle drop characteristic of shorter esters. This extended tail maintains anabolic signaling, supports continued gains in the final weeks, and provides a smoother bridge into PCT. Without the decanoate component, users would need to increase injection frequency or accept declining hormone levels toward cycle end.
For aggressive bulking, stack Testabol 400 at 600mg weekly with Nandrolone Decanoate at 400mg weekly for synergistic anabolic signaling and joint support. An oral kickstarter of Methandienone at 30–50mg daily for weeks 1–6 accelerates early hypertrophy. Aromatase inhibitor management with Exemestane or Anastrozole controls estrogen from both the testosterone and nandrolone components. This combination produces substantial, sustainable mass accretion with manageable side-effect complexity when supported by high protein intake and progressive overload training.
The acetate component ensures that serum testosterone begins rising within 24–48 hours of the first injection. Most users report improved training pumps, enhanced libido, and increased aggression within the first week. Visible hypertrophic changes and strength increases typically consolidate by weeks 3–4, with maximal results appearing between weeks 8 and 14. The decanoate ester means that late-cycle weeks continue to produce gains rather than plateauing, a key advantage over single short-ester protocols.
Proactive estrogen management is essential due to the substantial testosterone load. Aromatase inhibitors such as Anastrozole (Arimidex) at 0.5mg every other day or Exemestane (Aromasin) at 12.5–25mg every other day represent standard starting points. Users should monitor for nipple sensitivity, subcutaneous bloating, elevated blood pressure, and emotional lability. Blood work measuring estradiol at week 4–6 allows precise AI titration. The goal is to maintain estradiol within a healthy physiological range rather than suppressing it completely, as some estrogen supports joint health, mood stability, and HDL cholesterol.
Twice-weekly administration is the standard protocol. For a 600mg weekly dose, inject 0.75mL on Monday and 0.75mL on Thursday. For 800mg weekly, use 1.0mL per injection. This split maintains stable levels while keeping individual injection volumes moderate, reducing post-injection discomfort associated with high-concentration oils. Site rotation among gluteal, deltoid, and vastus lateralis muscles is essential to prevent lipohypertrophy and scar tissue accumulation over 12–16 week cycles.
High-concentration testosterone solutions can produce more pronounced post-injection pain than standard 250mg/mL preparations, though individual sensitivity varies significantly. Dragon Pharma's pharmaceutical-grade carrier oil and precise compounding minimize this risk compared to underground alternatives. Mitigation strategies include warming the vial to body temperature before drawing, injecting slowly over 60–90 seconds, using 25-gauge needles for smoother oil flow, and ensuring adequate site rotation. Most users adapt to the concentration within the first few injections.
PCT timing must account for the decanoate ester's extended clearance. Therapy should begin 14–18 days after the final injection to allow complete ester hydrolysis. A comprehensive protocol includes Clomiphene Citrate at 50/50/25/25mg and Tamoxifen Citrate at 40/20/20/10mg over four weeks. HCG at 500IU every other day for the two weeks preceding SERM initiation can prime testicular responsiveness. Given the 12–16 week typical cycle length, some practitioners extend PCT to 6 weeks or employ both SERMs simultaneously for more robust recovery. Blood work confirming restored LH, FSH, and total testosterone should precede any subsequent cycle.
While primarily optimized for bulking due to its substantial testosterone load and estrogenic potential, Testabol 400 can support recomposition or lean mass phases when combined with strict caloric control and aromatase inhibitor management. The high testosterone levels preserve muscle during energy deficit while supporting training intensity. However, the water retention from aromatization makes it less ideal for pure cutting than non-aromatizing compounds like Drostanolone or Trenbolone. Users seeking a defined aesthetic during Testabol 400 cycles should maintain aggressive AI protocols and consider adding a non-aromatizing agent.
Exogenous testosterone at 400–800mg weekly can produce significant hematocrit elevation and adverse lipid shifts. Protective measures include regular low-intensity cardiovascular exercise, high-dose omega-3 fatty acid supplementation (3–6g EPA/DHA daily), dietary fiber intake, and abstinence from alcohol. Blood pressure should be monitored weekly. Pre-cycle, mid-cycle (week 8), and post-cycle lipid panels are strongly recommended. For users whose hematocrit exceeds 54%, therapeutic phlebotomy may be necessary to reduce thrombotic risk.
Due to its high concentration, multi-ester complexity, and substantial total testosterone load, Testabol 400 is generally recommended for intermediate to advanced users who have already established their individual response to single-ester testosterone protocols. Beginners are typically advised to start with Testosterone Enanthate or Cypionate at 400–500mg weekly to understand their personal aromatization rate, androgenic sensitivity, and injection tolerance before transitioning to high-concentration blends. However, beginners with adequate guidance may initiate at the conservative 400mg weekly end of the dosing spectrum.
No. The 400mg per milliliter concentration and substantial weekly testosterone load create an exceptionally high virilization risk that is categorically unsuitable for female physiology. Even at micro-doses, the rapid onset of voice deepening, clitoral enlargement, facial and body hair growth, and menstrual disruption would be nearly certain. Women seeking anabolic support should explore significantly milder compounds such as Oxandrolone at conservative doses, or non-hormonal performance enhancers with established female safety profiles.
